Daniel Tobler
Effect of phosphodiesterase-5 inhibition on SystEmic Right VEntricular size and function. A multicentre, double-blind, randomized, placebo-controlled trial: SERVE.
Greutmann M, Tobler D, Engel R, Heg D, Mueller A, Frenk A, Gabriel H, Rutz T, Buechel R, Willhelm M, Trachsel L, Freese M, Ruperti-Repilado F, Valsangiacomo Buechel E, Beitzke D, Haaf P, Wustmann K, Schwitz F, Possner M, Schwitter J, Bouchardy J, Schwerzmann M, SERVE Investigators. Effect of phosphodiesterase-5 inhibition on SystEmic Right VEntricular size and function. A multicentre, double-blind, randomized, placebo-controlled trial: SERVE. Eur J Heart Fail 2023; 25:1105-1114.
13.06.2023Effect of phosphodiesterase-5 inhibition on SystEmic Right VEntricular size and function. A multicentre, double-blind, randomized, placebo-controlled trial: SERVE.
13.06.2023Eur J Heart Fail 2023; 25:1105-1114
Greutmann Matthias, Tobler Daniel, Engel Reto, Heg Dik, Mueller Arndt-Christian, Frenk André, Gabriel Harald, Rutz Tobias, Buechel Ronny Ralf, Willhelm Matthias, Trachsel Lukas, Freese Michael, Ruperti-Repilado Francisco Javier, Valsangiacomo Buechel Emanuela, Beitzke Dietrich, Haaf Philip, Wustmann Kerstin, Schwitz Fabienne, Possner Mathias, Schwitter Juerg, Bouchardy Judith, Schwerzmann Markus, SERVE Investigators
Myocardial blood flow and cardiac sympathetic innervation in young adults late after arterial switch operation for transposition of the great arteries
Possner M, Greutmann M, Stambach D, Tobler D, Fuchs T, Clerc O, Benz D, Gräni C, Mikulicic F, Vontobel J, Buechel R, Kaufmann P. Myocardial blood flow and cardiac sympathetic innervation in young adults late after arterial switch operation for transposition of the great arteries. Int J Cardiol 2019; 299:110-115.
13.07.2019Myocardial blood flow and cardiac sympathetic innervation in young adults late after arterial switch operation for transposition of the great arteries
13.07.2019Int J Cardiol 2019; 299:110-115
Possner Mathias, Greutmann Matthias, Stambach Dominik, Tobler Daniel, Fuchs Tobias A, Clerc Olivier F, Benz Dominik C, Gräni Christoph, Mikulicic Fran, Vontobel Jan, Buechel Ronny R, Kaufmann Philipp A
Patterns of Incidence Rates of Cardiac Complications in Patients With Congenital Heart Disease
Arslani K, Tobler D, Jost C, Ehl N, Rutz T, Bouchardy J, Schwerzmann M, Greutmann M, Zurek M, Roffler N, SACHER Investigators. Patterns of Incidence Rates of Cardiac Complications in Patients With Congenital Heart Disease. Can J Cardiol 2018; 34:1624-1630.
29.09.2018Patterns of Incidence Rates of Cardiac Complications in Patients With Congenital Heart Disease
29.09.2018Can J Cardiol 2018; 34:1624-1630
Arslani Ketina, Tobler Daniel, Jost Christine Attenhofer, Ehl Niklas, Rutz Tobias, Bouchardy Judith, Schwerzmann Markus, Greutmann Matthias, Zurek Marzena, Roffler Nico, SACHER Investigators
Prognostic Value of the Change in Heart Rate From the Supine to the Upright Position in Patients With Chronic Heart Failure
Maeder M, Brunner-La Rocca H, Pfisterer M, Julius B, Yoon S, Suter T, Kiencke S, Tobler D, Rickli H, Zurek M. Prognostic Value of the Change in Heart Rate From the Supine to the Upright Position in Patients With Chronic Heart Failure. J Am Heart Assoc 2016; 5
08.08.2016Prognostic Value of the Change in Heart Rate From the Supine to the Upright Position in Patients With Chronic Heart Failure
08.08.2016J Am Heart Assoc 2016; 5
Maeder Micha, Brunner-La Rocca Hans-Peter, Pfisterer Matthias E, Julius Barbara, Yoon Se-Il, Suter Thomas, Kiencke Stephanie, Tobler Daniel, Rickli Hans, Zurek Marzena
Interaction of Galectin-3 Concentrations with the Treatment Effects of β-Blockers and RAS Blockade in Patients with Systolic Heart Failure: A Derivation-Validation Study from TIME-CHF and GISSI-HF
Sanders-van Wijk S, Brunner-La Roccaenen H, Latini R, Rickli H, Tobler D, Tavazzi L, Gorini M, Rickenbacher P, Milani V, Masson S. Interaction of Galectin-3 Concentrations with the Treatment Effects of β-Blockers and RAS Blockade in Patients with Systolic Heart Failure: A Derivation-Validation Study from TIME-CHF and GISSI-HF. Clin Chem 2016; 62:605-16.
02.03.2016Interaction of Galectin-3 Concentrations with the Treatment Effects of β-Blockers and RAS Blockade in Patients with Systolic Heart Failure: A Derivation-Validation Study from TIME-CHF and GISSI-HF
02.03.2016Clin Chem 2016; 62:605-16
Sanders-van Wijk Sandra, Brunner-La Roccaenen Hans-Peter, Latini Roberto, Rickli Hans, Tobler Daniel, Tavazzi Luigi T, Gorini Marco, Rickenbacher Peter, Milani Valentina, Masson Serge
Impact of worsening renal function related to medication in heart failure
Brunner-La Rocca H, Maeder M, Rickenbacher P, Tobler D, Pfisterer M, Krause F, Rolny V, Eurlings L, Knackstedt C, TIME‐CHF investigators. Impact of worsening renal function related to medication in heart failure. Eur J Heart Fail 2014; 17:159-68.
30.12.2014Impact of worsening renal function related to medication in heart failure
30.12.2014Eur J Heart Fail 2014; 17:159-68
Brunner-La Rocca Hans-Peter, Maeder Micha, Rickenbacher Peter, Tobler Daniel, Pfisterer Matthias E, Krause Friedemann, Rolny Vinzent, Eurlings Luc, Knackstedt Christian, TIME‐CHF investigators
Increasing Mortality Burden among Adults with Complex Congenital Heart Disease
Greutmann M, Silversides C, Oechslin E, Williams W, Ivanov J, Held L, Haile S, Greutmann-Yantiri M, Kovacs A, Tobler D, Colman J. Increasing Mortality Burden among Adults with Complex Congenital Heart Disease. Congenit Heart Dis 2014
07.07.2014Increasing Mortality Burden among Adults with Complex Congenital Heart Disease
07.07.2014Congenit Heart Dis 2014
Greutmann Matthias, Silversides Candice K, Oechslin Erwin N, Williams William G, Ivanov Joan, Held Leonhard, Haile Sarah, Greutmann-Yantiri Mehtap, Kovacs Adrienne H, Tobler Daniel, Colman Jack M